Showing 109 results
-
Media Release /Despite endocrine therapy (ET), the risk of recurrence for people diagnosed with hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) early breast cancer (eBC…
-
Media Release /For over two decades, NOYCIA has fueled emerging research in Canada, driving scientific knowledge in cancerMontreal, QC – June 10, 2025 – Novartis Canada is pleased to announce the winners…
-
Media Release /• Applications are now being accepted, with $500,000 in grants to be awarded to projects focused on improving health equity in CanadaMontreal, Quebec, May 14, 2025 – Novartis…
